Subscribe
shutterstock_1524073421_karol_ciesluk
Karol Ciesluk / Shutterstock.com
27 February 2020AmericasSarah Morgan

Vir Biotech partners with WuXi on COVID-19 antibody treatment

Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.

More on this story

Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool